Radiotherapy Combined with Other Treatments in Rectal Cancer
- 1 March 1998
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 84 (2) , 238-246
- https://doi.org/10.1177/030089169808400223
Abstract
Since the first reports in the late 1950's, a large amount of data have been collected. The analysis of the main evidence from the major randomized trials will be analyzed in this paper according to preoperative, postoperative and chemoradiation approaches. Fifteen randomized preoperative trials were reported; they have been grouped according to the fractionation schedule. In the hypofractionation group (5 Gy for fraction), all five studies that delivered 3-5 doses in one week had a significant improvement in local control and one of them also showed improvement in survival. Operative mortality was higher in the radiotherapy arm if inadequate techniques had been applied. In 3 out of 8 studies with conventional fractionation there was a significant improvement in local control, but no impact in survival was detected. No studies with total dose lower than 34 Gy had an improvement in local control. None of the six randomized postoperative studies showed an improvement in local control or survival. In all trials the local control rate was uniform; ranging from 76% to 84%. Toxicity was higher in the radiotherapy arm. One preoperative and five postoperative randomized studies that used chemoradiation were analyzed. One postoperative chemoradiation study showed a significant improvement in survival in comparison to the surgery arm, and another showed the same advantage compared to the postoperative arm. Protracted infusional administration of 5FU concomitant to radiotherapy showed better survival than bolus administration. No advantages were shown in using MeCCNU or Levamisole in two studies. Toxicity was high and related to the dose and the modality of administration of the drugs in order to adequately treat the different stages of rectal cancer, patients must be carefully selected in order to prescribe the most effective and the least toxic treatment for the individual stage; organ preservation should be an essential goal for its impact on quality of life, and the cost estimates should be taken into account.Keywords
This publication has 51 references indexed in Scilit:
- Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of CancerBritish Journal of Surgery, 1997
- Treatment of non-disseminated cancer of the lower rectumBritish Journal of Surgery, 1996
- Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failureEuropean Journal Of Cancer, 1994
- Adjuvant preoperative radiotherapy for locally advanced rectal carcinomaDiseases of the Colon & Rectum, 1994
- Adjuvant treatment in the curative management of rectal cancer: a critical review of the results of clinical randomised trialsEuropean Journal Of Cancer, 1993
- Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studiesEuropean Journal Of Cancer, 1993
- Pre‐operative and post‐operative radiotherapy and rectal cancerWorld Journal of Surgery, 1992
- Results of radical surgery for rectal cancerWorld Journal of Surgery, 1992
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985